Therefore, randomized and carefully controlled studies can address the relation between prostate cancer and nutrition
doi: 10.18632/oncotarget.26592 55 KuasneHRodriguesISLosi-GuembarovskiRReisMBFugantiPEGregrioEPet al
Phase I data presented at the American Heart Association (AHA) 2025 meeting and published in The New England Journal of Medicine ( NEJM ) showed deep, dose-dependent reductions in ANGPTL3 (up to 89%) with corresponding decreases in triglycerides and LDL cholesterol, including in patients already on standard lipid-lowering therapy
Arbutin w/o/w nanoemulsions that were co-encapsulated with coumaric acid showed enhanced encapsulation efficiency, increased drug stability, sustained drug release, and improved skin delivery in comparison to the free drug (Wen et al., 2006a
Technological advancements in external beam radiation therapy (EBRT): an indispensable tool for cancer treatment
Human clinical trial data remains sparse, and the compound shares much of BPC-157's regulatory history: popular before 2023, restricted under Biden-era FDA action, and now under consideration for reinstatement